Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights North America Companion Animal Drugs Market

Published Date : Aug 2023

Veterinary drugs are a critical factor in animal husbandry and contemporary-day meal production; however, their residues can persist in animal-derived ingredients. To reduce those risks, the countrywide government set up strict controls for the authorization, labeling... View more

Coherent Market Insights Head Lice Drug Market

Published Date : Aug 2023

Lice are parasitic insects that can be found on people's heads and bodies, including the pubic area. There are three types of lice that affect humans: body lice, head lice, and pubic lice. Lice are tiny, wingless insects that feed on human blood. Lice spread from pers... View more

Coherent Market Insights Anti Neprilysin Market

Published Date : Aug 2023

Anti-neprilysin drugs are mostly used for acute heart failure, cancer pain, hypertension, Alzheimer’s disease, and other diseases. The most commonly used anti-neprilysin is Sacubitril/valsartan thatis sold under the brand name Entrest. It consists of the neprily... View more

Coherent Market Insights North America And Europe Age Related Macular Degeneration Therapeutics Market

Published Date : Aug 2023

Age-related macular degeneration (AMD) is an eye disease that can blur central vision. It happens when aging causes damage to the macula the part of the eye that controls sharp, straight-ahead vision. The macula is part of the retina (the light-sensitive tissue at the... View more

Coherent Market Insights Uae Heart Failure Drugs Treatment Market

Published Date : Aug 2023

Congestive heart failure, or heart failure, is a long-term condition in which the heart cannot pump blood well enough to meet body’s needs. As during heart failure, heart is unable to pump enough blood therefore blood accumulates in other parts of body. Most of ... View more

Coherent Market Insights Hemoglobinopathy Treatment Drugs Market

Published Date : Aug 2023

The hemoglobinopathies encompass all genetic diseases of hemoglobin. They fall into two main groups: thalassemia syndromes and structural hemoglobin variants (abnormal hemoglobins). α and β thalassemia are the main types of thalassemia; the main structural ... View more

Coherent Market Insights Amino Acid Market

Published Date : Aug 2023

Amino acids are organic compounds that constitute the building blocks of proteins and serve as vital nutrients for human beings. They are also used as flavor enhancers, dietary supplements, and industrial chemical intermediates. The major amino acids include glutamic ... View more

Coherent Market Insights Achondroplasia Treatment Market

Published Date : Jul 2023

Achondroplasia is a form of short-limbed dwarfism. Achondroplasia is characterized by an average-sized trunk, short arms and legs, notably short upper arms and thighs, a limited range of motion at the elbows, and an enlarged head. Spinal stenosis, a narrowing of the s... View more

Coherent Market Insights Ragweed Pollen Allergy Treatment Market

Published Date : Jul 2023

Ragweed is an allergen for people allergic to ragweed. Ragweed pollen is made of tiny particles that float through the air and cause allergy symptoms in people who are allergic to ragweed. Of all ragweed allergy symptoms, cough, runny nose, and an itchy throat are the... View more

Coherent Market Insights Somatropin Market

Published Date : Jul 2023

Somatropin injections are used to replace growth hormone (a natural hormone produced by the body) in adults and children with growth hormone deficiency. Somatropin injections are also used to increase growth in children with certain conditions that affect normal growt... View more

Coherent Market Insights Plasma Therapy Market

Published Date : Jul 2023

Plasma therapy is a promising treatment against coronaviruses, and many rare other and serious disorders. The blood that is donated by the donor is processed in a processing facility to obtain plasma. Similarly, for the treatment of coronavirus-infected patients, the ... View more

Coherent Market Insights Anhydrous Dibasic Calcium Phosphate Market

Published Date : Jul 2023

Anhydrous dibasic calcium phosphate, also known as dicalcium phosphate, is produced by the neutralization of calcium hydroxide with phosphoric acid, which precipitates the dihydrate as a solid. At 60 °C, the anhydrous form is precipitated. The calcium phosphate sa... View more

Coherent Market Insights Liver Diseases Therapeutics Market

Published Date : Jul 2023

Liver is the largest organ of the human body. It helps to digest food, store energy, and remove poisons. There are many kinds of liver diseases like diseases caused by viruses such as hepatitis A, hepatitis B, and hepatitis C. Diseases can also be caused by drugs, poi... View more

Coherent Market Insights Alpha Emitter Market

Published Date : Jul 2023

Alpha particles are composite particles consisting of two protons and two neutrons tightly bound together. They are emitted from the nucleus of some radionuclides during a form of radioactive decay, called alpha-decay. An a... View more

Coherent Market Insights Asthma And Copd Market

Published Date : Jul 2023

Asthma is a condition in which a patient’s airways narrow and swell and may produce extra mucus. This can make breathing difficult and trigger coughing, a whistling sound (wheezing) when a patient breathes out and shortness of breath. For some people, asthma is ... View more

Coherent Market Insights Immune Health Supplements Market

Published Date : Jul 2023

Immune health supplements also called immunity boosters play a major role in advanced healthcare by supporting healthy aging and preventing malnutrition and vitamin deficiencies. Immune health supplement products consist of vitamins, proteins, minerals, lipids, fibers... View more

Coherent Market Insights Infertility Drugs And Devices Market

Published Date : Jul 2023

Infertility Drugs and Devices used for treating infertility in male and female. Factors such as endometriosis, ovarian disorders, uterine disorders, tubal disorders, and hormonal disorders are the major cause of female infertility, whereas male infertility is caused b... View more

Coherent Market Insights Allergic Asthma Therapeutics Market

Published Date : Jul 2023

Allergic asthma, also known as allergy-induced asthma, is a chronic inflammatory condition Allergic asthma is a breathing condition where the airways you breathe through tighten when someone inhale an allergen. Allergic asthma is when someone develop breathing difficu... View more

Coherent Market Insights Osteogenesis Imperfecta Treatment Market

Published Date : Jul 2023

Osteogenesis imperfect, or OI, is a genetic disorder that affects the bones and also prevents the body from building strong bones. This disease makes the bones brittle and breaks easily without any cause. OI is referred to as imperfect bone formation, and people suffe... View more

Coherent Market Insights Hemorrhagic Shock Treatment Market

Published Date : Jul 2023

Hemorrhagic shock is a condition resulting in tissue perfusion and inadequate delivery of oxygen and nutrients to cells. A traumatic injury can cause hemorrhagic shock if the bleeding does not stop immediately. The primary treatment for hemorrhagic shock is immediate ... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.